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Femtosecond to nanosecond dynamics of O2 rebinding to human
WT myoglobin and its mutants, V68F and I107F, have been studied
by using transient absorption. The results are compared with NO
rebinding. Even though the immediate environment around the
heme binding site is changed by the mutations, the picosecond
geminate rebinding of oxygen is at most minimally affected. On
the other hand, the V68F (E11) mutation causes drastic differences
in rebinding on the nanosecond time scale, whereas the effect of
the I107F (G8) mutation remains relatively small within our 10-ns
time window. Unlike traditional homogeneous kinetics and mo-
lecular dynamics collisional simulations, we propose a ‘‘bifurcation
model’’ for populations of directed and undirected dynamics on
the ultrafast time scale, reflecting the distribution of initial protein
conformations. The major mutation effect occurs on the time scale
on which global protein conformational change is possible, con-
sistent with transitions between the conformations of directed and
undirected population playing a role in the O2 binding. We discuss
the relevance of these findings to the bimolecular function of the
protein.
femtobiology  molecular recognition
Myoglobin (Mb) is considered as the hydrogen atom ofbiology (1), and numerous studies have been carried out
to elucidate its function, the storage of oxygen in vertebrate
muscle cells. In addition to storing oxygen, it can interact with
other important small molecules, for example NO and carbon
monoxide (2, 3), making it a prototype system for the study of
molecular recognition (4). One persistent question in the study
of Mb concerns the ligand recognition and its correlation to
protein dynamics. X-ray study has revealed that Mb is highly
compact and has to undergo conformational f luctuation to form
effective ‘‘channels’’ for the release of the ligand (ref. 1 and
references therein).
Tilton et al. (5) have shown that, in addition to the distal cavity
next to the heme group, there are four folding defects inside the
protein denoted as Xe1–Xe4 binding sites (Fig. 1 Upper), num-
bered in the decreasing order of affinity of Xe to these locations.
These highly nonpolar cavities are believed to be involved in
ligand migration (5). Cryogenic x-ray studies of photolysed WT
and mutant carbonmonoxymyoglobin (MbCO) have indicated
that CO ligand resides in the distal cavity (6, 7) as well as in the
Xe4 (8, 9) and Xe1 (8, 10) sites. More recently, time-resolved
x-ray studies on samples near room temperature revealed CO
residence times of ligands in these sites, from 30 ns to 10 s for
WT and recombinant mutants (11–13).
Since the pioneering work of Frauenfelder and coworkers in
1975 (14) on ligand geminate rebinding at low temperature it is
known that ligand–Mb interaction involves energy landscapes of
multiple conformational substates and intermediates. Two per-
spectives usually are discussed in the literature to account for the
rebinding of O2 and other small molecules. One of these, the
multiple-site model, relates the rebinding rate to the physical
location of the ligand inside the protein (15). The central theme
is that discrete intermediates exist and can be mapped out on a
static energy landscape. In contrast, rebinding may be controlled
by time-dependent barrier changes involving transitions among
conformational substates, as manifested in the nonexponential
behavior of rates (16).
Protein engineering (mutagenesis), ultrafast spectroscopy,
and computational simulations all have been invoked to study
dynamics in Mb. Residues located near the heme iron center and
bordering the Xe4 site are demonstrated to affect the ligand
nanosecond geminate rebinding as well as the overall bimolec-
ular rebinding kinetics (8, 13, 15, 17–37). It is generally believed
that mutations at these positions alter the rebinding kinetics by
enhancing or restricting the ligand movement according to the
multiple-site model (15). Theoretical simulations have been used
to investigate the effect of mutation on ligand trajectories upon
photolysis (24). Those show the ligands being confined in a place
that is within 4 Å of the iron center in a mutant where Val-68 has
been mutated to phenylalanine (V68F mutant). This space
restriction has been proposed to be the reason for the observed
high geminate rebinding for the V68F mutant.
Champion and coworkers (38) have carefully studied, with
femtosecond time resolution, the transient absorption dynamics
of O2-bound native horse heart Mb and reported a geminate
recombination lifetime of 5 ps, similar to the 6.4  2-ps
geminate recombination lifetime reported from an earlier pico-
second study (39). For the mutants, no femtosecond O2 binding
studies have been reported. Experiments on the sperm whale
V68FO2 system have been conducted with 35-ps laser pulses
(30), but these could not resolve the ultrafast recombination
process. Because the picosecond geminate rebinding is the
ultimate step to form the protein–ligand bond, information in
this time regime is critical for the understanding of the elemen-
tary steps of molecular recognition.
From this group, an earlier effort focused on the dynamics,
kinetics, and thermodynamics of molecular recognition of O2 by
a Mb and hemoglobin mimic, cobalt picket-fence porphyrin (40,
41). In this article, we report a study of oxygen recognition in real
proteins, the recombinant human Mb and its mutants, from the
femtosecond to nanosecond regime. We have chosen the mu-
tants V68F and I107F (in which isoleucine at residue 107 is
replaced by phenylalanine), which alter two of the residues that
border the Xe4 site (Fig. 1 Lower). With femtosecond resolution,
we were able to probe the mutant behavior with an extended
window up to 10 ns. From the results, we propose a bifurcation
dynamics model for which direct O2 rebinding occurs for some
conformational populations on the femtosecond to picosecond
time scales before protein conformational f luctuation can occur.
This directed ultrafast recombination contrasts with the undi-
rected diffusive ligand migration on the nanosecond to micro-
second time scale.
Materials and Methods
Biochemistry: Protein Expression and Mutants. The synthetic gene
for human WT Mb, which carries G80A and C110A mutations,
Abbreviations: Mb, myoglobin; MbCO, carbonmonoxymyoglobin; MbO2, oxymyoglobin;
MbNO, nitrosylmyoglobin; deoxyMb, deoxymyoglobin.
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was a generous gift from Steven Boxer (Stanford University,
Stanford, CA). The gene was subcloned into pET-19b plasmid
(Novagen), and V68F and I107Fmutations were carried out with
Quikchange (Stratagene). All protein sequences were verified by
DNA sequencing. Proteins were expressed in BL21 (DE3) cells
and purified by Ni-NTA (Qiagen, Valencia, CA) affinity column,
and protein identities were confirmed by MS and N-terminal
partial sequencing. All of the proteins have a His tag at the N
terminus. MS spectra show that the His tag in V68F mutant
remains mostly intact, but in WT and I107F 13 aa of the tag are
cleaved. CD spectra of WT, V68F, and I107F were similar to
each other. The ferric protein was then reduced with sodium
dithionite and passed through a Sephadex G-25 column (Nap10,
Amersham Pharmacia Biosciences) under oxygen-free condi-
tion. The quality of deoxymyoglobin (deoxyMb) was checked by
UV-visible. Oxymyoglobin (MbO2) or nitrosylmyoglobin
(MbNO) were obtained by bubbling pure oxygen or NO through
the pure deoxyMb sample. All transient absorption measure-
ments were carried out on samples in 0.1M phosphate buffer, pH
7.0 at 21°C, at concentrations of25 M to give an OD1.2 for
the Soret band in a 5-mm optical cell. The cell was continuously
stirred, and sample degradation was monitored during experi-
ments by UV-visible of the Soret band as well as the Q band for
traces of the ferric state generated by laser irradiation. New
MbO2 solution was used when 5% deviation from the initial
UV-visible spectrum was observed. Much larger spectral varia-
tions in the UV (250–400 nm) were seen among MbNO samples
without noticeable change in the characteristic heme absorption
bands or in transient absorption.
Femtosecond Spectroscopy. For these experiments, a Hurricane
laser system (Spectra-Physics) produced 100-fs pulses at 804
nm (fundamental) with 900-Hz repetition rate and 1 mJ energy
(Fig. 2). These pulses pumped an optical parametric amplifier
(OPA), and probe pulses at 436 nm were generated by frequency
tripling the OPA signal at 1,308 nm. The pump pulses at 402 nm
were obtained by doubling the residual of the fundamental beam
after the OPA in a -barium borate crystal. The probe pulses
were divided into two beams, one passing through the sample
and the other serving as a reference. The time delay between
pump and probe was controlled by a translation stage. By setting
up a triple-pass delay line, we could scan up to 10 ns of delay. For
the long time range data, transient shapes were very sensitive to
imperfect laser collimation and alignment through the variable
path of the delay line, so measurements were made of all of the
different samples in this study under controlled conditions to
allow unambiguous comparison of the transients recorded. For
example, six samples, with O2 and NO bound to each of the three
proteins, were run consecutively under the same conditions.
Transients of samples with known long lifetimes (specifically,
WT-O2 and I107F-O2 as seen in Fig. 3 Lower) also were used to
calibrate for maximum influence of the delay line over the 9-ns
delay range and the behavior is robust; that is, the conclusions
reported here are totally independent of the effect of calibration.
The data are shown in the figures only as recorded.
Typical pump pulse energy was 60 nJ to minimize sample
degradation, and probe energy was 0.8 nJ. These two beams
were focused by a single 30-cm focal length lens and aligned to
intersect within the sample cell, crossing at an angle of 10°.
After the sample, the pump beam was blocked by two apertures
and further reduced with a GG435 sharp-cutoff filter. The probe
beam was focused at a photodiode for measurement. The output
from the photodiode was gated and integrated by a boxcar
integrator and normalized to the similarly processed reference.
The log of the ratio between thus processed transmitted probe
intensities with and without pump light generated the transient
absorption, A. The typical transient absorption maximum was
0.4%.
Experimental Results
Protein (Mb)–O2. The femtosecond-resolved transient absorption
of WT, V68F, and I107F mutants of human MbO2 is shown in
Fig. 1. X-ray protein structures. (Upper) Ribbon model of sperm whale WT
Mbwith Xe binding sites highlighted according to ref. 5. For clarity, twoheme
side chainsarenotdrawnhere,but canbe seen in Lower. The tworesidues (107
and 68) indicated above the heme are the same in human and sperm whale
Mb, but only the spermwhaleMb V68Fmutant x-ray structure is available for
the comparison in Lower. (Lower) Expanded view of the distal pocket of the
superimposed structures ofWT and V68F. The highlighted portions of theWT
(ProteinDataBank IDcode1A6N)andV68Fmutant (ProteinDataBank IDcode
1MLK), including the side chains of residues 107 and 68, are shown in red and
white, respectively. The remainders ofboth structures are shown inblue. I107F
mutant is not shown because of a lack of crystal structure information.
Fig. 2. Schematic layout of the femtosecond transient absorption apparatus
with pulse wavelengths indicated. OPA, optical parametric amplifier; BBO,
-barium borate.
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Fig. 3 for excitation at 402 nm and probing at 436 nm. The data
sets compared for each time range were collected in the same
experimental run, ensuring uniformity of conditions. On the
picosecond time scale, we observed a decay component with a
lifetime of 6  1 ps and an amplitude of 30  6% of the peak
signal for all three Mb species (Fig. 3 Upper), similar to the
picosecond behavior in horse heart Mb reported for 400-nm
excitation and 438-nm probing (6.0 ps, 33%) (38). The differ-
ences in lifetimes and amplitudes among the transients shown in
Fig. 3 are within the error range given and are typical of the
experimental variability for any single mutant.
In contrast, the dynamics of the V68F mutant in the nano-
second regime is strikingly faster than that for WT and I107F
mutants and the decay amplitude is much larger (Fig. 3 Lower).
The decay rates for WT and I107F are too slow to be measured
accurately in our 10-ns window, but literature values (33) and our
measurements allow us to estimate the degree of distortion of the
transients caused by delay line effects and calibrate the V68F
data accordingly. With or without such calibration, all V68F
mutant transients can be fit reasonably well to a single nano-
second lifetime (near 3 ns) with a baseline offset near 10% of the
maximum signal (such a fit is plotted with the data in Fig. 3),
although two lifetimes on the nanosecond time scale and a
smaller offset clearly give a superior fit in all cases. However,
given that even the 10-ns time range is too short to measure
directly the long time plateau signal level, various combinations
of parameters, with lifetimes ranging from 0.5 to 6 ns, produce
equally satisfactory biexponential fits. Thus we can only say that
the decay in our time window is apparently slightly nonexpo-
nential and note that such behavior is not unexpected in a
dynamic protein environment. The decay on the nanosecond
time scale measured here for human V68FO2 has a correspond-
ing component in the dynamics of sperm whale V68FO2
previously reported as a single exponential of 7-ns lifetime after
photolysis, but using pulses of 17 or 9 ns (24, 30).
Protein (Mb)–NO. Experiments like those above on MbO2 also
have been performed on MbNO. Transient absorption of WT
and I107F MbNO is virtually indistinguishable on the picosec-
ond and nanosecond time scales (Fig. 4). Four lifetimes were
used in the global fit shown in Fig. 4 to the full time range of the
WT measurements, with a 1% offset asymptote reached after
several nanoseconds. Unlike for MbO2, the transient absorption
of the V68F mutant of MbNO is significantly different from that
of WT and I107F on the picosecond time scale and fits to two
picosecond lifetimes (8 and 35 ps) with an offset of 1–2%.
Further time dependence of the V68F signal is not measured
because of the small amplitude remaining after 150 ps.
Discussion
Protein Dynamics and Recognition Landscape. In our measure-
ments, the response to femtosecond photolysis of MbO2 is
monitored at the peak of the deoxyMb Soret band and A
ref lects, in general, the amount of unligated Mb. In the
detailed transient absorption study of Champion and cowork-
ers (38), it was found that vibrational cooling also contributed
signals at a very early time (t  2 ps) when probing at the
wavelength of peak static absorption for horse heart deoxyMb,
Fig. 3. Femtosecond time-resolved geminate rebinding of O2 with Mb. The
transient absorption difference is recorded at 436 nm after photolysis at 402
nm. Short (Upper, fs to ps) and long (Lower, ns) time scans are presented. Note
that the nanosecond transients have beennormalized to intensitiesmeasured
at the plateau of the picosecond transients (t  60 ps). Fit curves are plotted
with each of the short time transients andwith theV68F data on the long time
range.
Fig. 4. Femtosecond time-resolved geminate rebinding of NOwithMb. The
transient absorption difference is recorded at 436 nm after photolysis at 402
nm. Short (Upper, fs to ps) and long (Lower, ns) time scans are presented for
WT and I107F. A five-component global fit to the WT measurements and a
three-component fit to the V68F transient are plotted with the data.
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MbCO, MbO2, and MbNO. For MbO2, a 4–to 6-ps decay
component was observed at all probe wavelengths and as-
signed as primarily caused by geminate recombination of
oxygen to the ground state of the unbound protein for several
reasons: (i) the 4–to 6-ps decay component did not appear in
the transient absorption of deoxyMb; (ii) it did not appear in
the transient absorption of MbCO, which has no picosecond
geminate rebinding; (iii) it was observed with opposing signs
when probing at 418 nm, the Soret band of MbO2, and 438 nm,
the deoxyMb Soret band; and (iv) it was absent when probing
at the isosbestic points of the MbO2 spectrum. The amplitude
of this component relative to the residual A changed with
probe wavelength, which would not occur if it was totally
caused by geminate recombination at all wavelengths, but its
fraction was smallest for probing at the deoxyMb Soret band,
as in our experiments. Accordingly, A is considered to ref lect
the amount of unligated Mb over all time ranges, and as such,
the experimental geminate rebinding rates and the fractions of
ligand escaping on the picosecond and nanosecond time scales,
from this work and the literature, are given in Table 1.
The most significant observations made in this work can be
summarized as follows: (i) As shown schematically in Fig. 5 Top,
with the newly femtosecond-resolved transients of MbO2 re-
ported here, the response to photolysis of the WT and mutants
can be fully characterized, revealing that behaviors differ dis-
tinctly among mutants on long time scales, whereas on the
ultrafast time scale they are essentially the same. The overall
behavior is reflective of the dynamics of O2 binding and un-
binding. (ii) Although themutation at position 68 (Fig. 1Bottom)
introduces a structural blockage, through the phenyl group, in
the immediate vicinity of the iron center, the picosecond be-
havior is not greatly altered. This response could not be observed
in previous studies of the V68F mutant because of the 35-ps
pulses used (30). (iii) The ultrafast response for the I107Fmutant
is likewise nearly the same as for theWT. (iv) On the nanosecond
time scale, V68F mutation enhances the rates by more than an
order of magnitude, qualitatively consistent with previous work
on sperm whale Mb using 9- to 17-ns pulses (24, 30). For I107F,
the nanosecond response is on a much longer time scale. (v)
Finally, we repeated the same experiments with NO instead of
O2 and obtained results in qualitative agreement with other work
at different pump and probe wavelengths for WT and V68F
sperm whale Mb (31), WT horse heart Mb (39), and WT human
Mb (42). Our measured transient for WT over early time (Fig.
4 Upper) is very similar to that recorded for WT horse heart
MbNO over the same time range and with the similar pump and
probe wavelengths of 400 and 438 nm, respectively (38), as
evidenced by a comparison of parameters obtained when fitting
this restricted time range as a simple biexponential: 12.2 ps, 37%
and 187 ps, 63% for our data vs. 13.0 ps, 35% and 190 ps, 65%
in ref. 38.
With these observations and comparisons, the following pic-
ture of the protein dynamics and energy landscape emerges.
After the femtosecond initiation of O2 release, the ligand first
dwells at a distal site close to the iron center, in a cavity with
direct access to Xe4 (see Fig. 1). Then it could either geminately
rebind or escape to sites of minimum energy, e.g., Xe4, identified
by x-ray diffraction as one collection site for CO after photolysis
of MbCO (11, 12). The observed geminate recombination is
Table 1. Observed rates and fractions for O2 geminate rebinding to human WT, V68F, and
I107F Mbs from transient absorption at 436 nm
Mb
This work Literature*
1, ps esc(ps), % 2, ns esc(ns), % 2, ns esc(ns), %
WT 6  1 70  6 55† 55
V68F 6  1 70  6 2.7  0.6‡ 9  5
I107F 6  1 70  6 45 27
esc(ps) and esc(ns) are the escape fractions in the picosecond and nanosecond regime. These are the ratios
between the offset and the initial value of the transient absorption in the appropriate time range.
*Data are from ref. 33.
†The WT transient could be fit best with two nanosecond components with lifetimes of 27 and 135 ns.
‡The fit of all V68F nanosecond transients improved with the use of two exponential components and an offset,
but fit parameters were not well determined in such fitting. See text.
Fig. 5. Dynamics and landscapes for Mb recognition of oxygen. (Top)
Illustration of the time evolution of 436-nm transient absorbance of WT
(blue), I107F (green), and V68F (red) MbO2 after femtosecond photolysis. The
positive signal change, which is proportional to the population of unligated
Mb, decays on multiple time scales as the protein rebinds O2. (Middle) Sche-
matic free energy landscapes for O2 migration away from the heme binding
site in WT (blue) and V68F (red) Mb. (Left) Picosecond, directed dynamics
(unaffectedbymutation). (Right) Nanosecond, undirecteddynamics (affected
by mutation). (Bottom) Schematic representation of a bifurcation of Mb
conformations associatedwith directed (Left) and undirected (Right) ultrafast
dynamics. GR, geminate recombination.
Wang et al. PNAS  December 28, 2004  vol. 101  no. 52  18003
CH
EM
IS
TR
Y
BI
O
PH
YS
IC
S
ultrafast (6 ps), and if it is driven by the kinetics of a
homogeneous protein ensemble, then the V68F mutant (which
changes the environment of the Xe4 site) should result in a
significant change of the rate and the fraction rebound, contrary
to our observation. For example, the blue energy landscape in
Fig. 5 Middle Right is illustrative of one in which the forward
migration to Xe4 would be faster than rebinding, consistent with
the observed 7030 escape vs. rebinding branching ratio. Be-
cause the V68F mutation reduces the Xe4 cavity to half of the
space in WT (red potential curve in Fig. 5), the escape process
is hindered, which should enhance the rebinding process. The
molecular dynamics simulations using the locally enhanced
sampling method predicted such a mutant effect (24). In those
simulations, for V68F mutant, the phenylalanine at residue 68
occupies the same spot in the Xe4 cavity in which ligands gather
in the WT. Consequently, the ligands are forced to reside in the
primary distal site, causing more collisions between the ligands
and the iron center.
The unchanging observed rate and fraction of the picosecond
rebinding in our experiments would require, for a homogeneous
system, a constant value for both the forward rate (to Xe4) and
the rebinding rate, contradicting the above predictions of the
V68F mutant effect. To account for the discrepancy, we propose
that the ultrafast primary step follows the dynamics of the
bifurcation model, which was found to be significant in ultrafast
chemical and biological reactions (ref. 43 and references
therein), such as DNA gating of electron transfer (44, 45). In this
case, because of protein conformations with low free energy
barriers to recombination, the directed population will rebind
within the first few ps (Fig. 5 Middle Left and Bottom Left),
whereas the undirected population will be in conformations
capable of recombination after thermal and intramolecular
motions on a longer time scale (Fig. 5 Middle Right and Bottom
Right). Because the escape fraction is determined by the con-
formational bifurcation rather than the competition between
forward and backward rates, as long as recombination is highly
favored in the directed population of the WT, the obstruction of
the Xe4 cavity in V68F will have little effect on the ultrafast time
scale (Fig. 5 Middle Left).
The reasoning given above based on competition between
forward and backward rates on a static energy landscape also
should apply when photolysis-initiated local conformational
dynamics (e.g., motion of the Fe atom relative to the heme plane)
are important in the picosecond process (46, 47). That is, if
mutation causes the pronounced change in the ligandFe colli-
sion frequency that is predicted by molecular dynamics simula-
tions for V68F (24), the probability of reforming the ligand-Fe
bondmust change accordingly and at least the picosecond escape
fraction would clearly reflect this change in a homogeneous
sample.
This bifurcation picture raises an important point about the
nature of the energy landscape and trajectory of motions. The
instantaneous dissociation of O2 generates a nonequilibrium
protein ensemble that then evolves toward equilibrium. On the
femtosecond to picosecond time scale, the protein is essentially
a frozen matrix and only small and local conformational changes
(lower level of conformational tiers) may be involved. The
directed geminate recombination takes place on one family of
conformations that is adapted to ensure efficient reformation of
the metal–ligand bond on a static or minimally f luctuating
landscape, and we observe no change of rates or fractions with
mutation.
Larger and global motions in the protein occur at longer time.
Those motions involve transitions of higher tiers of conforma-
tional structures. On such time scales, the trajectories visit a large
phase space and the landscape fluctuations play a role. Trajec-
tories are the result of many collisions in the cavity and barriers
and wells can fluctuate. For example, the landscape may evolve
from one of undirected dynamics, as in Fig. 5 Right, to that in Fig.
5 Left, which will direct the ligand to immediate bond formation.
In such a situation, a mutant effect on the protein global
f luctuation will alter the rebinding dynamics. Indeed, the ob-
served delayed mutant effect on recombination could be an
indication of the time scale of protein global dynamics and
thermal fluctuations and how they are affected by the mutations.
For MbCO, time-resolved x-ray studies (11, 12) and spectro-
scopic studies (46, 48, 49) have indicated a wide range of time
scales of photolysis-driven global conformational changes, from
hundreds of picoseconds to microseconds. On the other hand,
modification of the local energy landscape by steric hindrance
undoubtedly also will have its effect on nanosecond and longer
time dynamics. It is noteworthy that, even though residue 107 is
located close to residue 68, mutant I107F does not cause as
significant a deviation from the WT as V68F. This may be
because these two spatially close residues are involved in the
global dynamics differently, perhaps because they are on differ-
ent helices.
When O2 rebinds from the solvent bimolecularly, it can be
expected to be subject to the same processes as when photolyt-
ically released. O2 must reenter the distal cavity, possibly after
passage through other intermediate states. On the time scale of
this migration, protein conformational dynamics will clearly be
important, as the energy landscape and barrier heights fluctuate.
The V68F mutation slows down the initial process by a factor of
13 relative to WT (50), whereas the I107F mutation again has
only a moderate effect (35% rate reduction) (33). The mag-
nitudes of these changes are consistent with the influence of
these specific mutations on protein dynamics inferred from the
picture of dynamic control on the nanosecond rates.
In the Mb mimic, cobalt picket-fence porphyrin with methy-
limidazole base (B-CoP), analysis of the global rebinding dy-
namics showed that an intermediate B-CoPO2 state was
formed that had only a 2% probability of going on to form the
ligand–metal bond (40). In addition, the ultrafast dynamics of
this system showed no geminate recombination of O2 (41).
Replacement of the cobalt center with iron results in a much
higher affinity for O2 (51, 52) and 43% geminate recombination
with a 25-ps lifetime (53). For the three Mb mutants studied
here, with 30% recombination on the picosecond time scale,
recombination from intermediate states on the nanosecond time
scale ranges from 45% to 91% [1  esc(ns) from Table 1]. These
results all are consistent with the concept that the existence of
conformations leading to directed ultrafast dynamics enhance
the efficiency of the binding function, even in a relatively simple
system like the picket fence.
Recombination to WT Mb on the picosecond time scale is
much more efficient for NO than for O2. Because the intrinsic
chemical reactivity, orientation when the ligand is bound to
heme, and electrostatic and hydrogen-bonding interaction with
the protein moiety all are so different for these two ligands, a
difference in the binding process is not surprising. In contrast to
O2, the V68F mutant effect for NO is dramatic within the first
10 ps of photolysis (Fig. 4). This behavior is consistent with the
expectations from homogeneous kinetics and local structural
changes, as modeled in the above-mentioned molecular dynam-
ics simulations (24), and the role of conformations such as those
associated with directed dynamics for O2 may be very different
for NO because of the different binding. More recent theoretical
work on NO rebinding using the reactive molecular dynamics
method shows that on this short time scale fluctuations in the
immediate vicinity of the binding site control the NO nonexpo-
nential rebinding (47).
Conclusion
With femtosecond time resolution, the picosecond to nanosec-
ond geminate rebinding dynamics of oxygen to Mb WT, V68F,
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and I107F mutants has been studied. The lack of a pronounced
mutation effect on the initial rebinding for either mutant shows
that this process is kinetically isolated from the distal pocket
environment through which the ligand moves on the nanosecond
time scale. The bifurcation that allows this isolation is under-
stood in terms of a distribution of conformational structures,
with one set of conformations leading to directed O2-Fe bond
formation without sampling a large phase space. These struc-
tures may be functionally important, with protein global con-
formational f luctuations into such structures guiding the O2 to
efficient binding once it has reached the distal cavity from the
solvent. The fact that V68F mutation causes a drastic effect on
rebinding dynamics on the time scale of protein global f luctu-
ation is consistent with this concept of directed populations. The
existence of conformations optimized for directed bonding in
MbO2 should be important for an efficient biological function
(43, 54, 55).
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